Predictors of Clinical Response to Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Cirrhotic Patients With Refractory Ascites

DeschĂȘnes, Marc; Dufresne, Michel-Pierre; Bui, Bao; Fenyves, Daphna; Spahr, Laurent; Roy, Louise; Lafortune, Michel; Pomier-Layrargues, Gilles
May 1999
American Journal of Gastroenterology;May1999, Vol. 94 Issue 5, p1361
Academic Journal
OBJECTIVE: Transjugular intrahepatic portosystemic shunt (TIPS) is used increasingly its a treatment for refractory ascites. The aim of the present study was to determine the prognostic value of different panuneters in predicting a favorable evolution following TIPS in a cohort of 53 cirrhotic patients without organic renal disease and with refractory ascites. METHODS: Patients were classified as good responders if they survived more than 6 months, without severe chronic hepatic encephalopathy and with good control of ascites. The prognostic value for a good outcome was evaluated using age, creatinine clearance, plasma renin activity, plasma aldosterone, and Pugh score. RESULTS: Good control of ascites was obtained in 90%. The cumulative survival rate was 54% at 6 months, 48% at 1 yr, and 39% at 2 yr. The vast majority of patients died of complications of hepatic insufficiency. Severe chronic hepatic encephalopathy developed in 26%. Overall, a good clinical response was observed in 47%. Creatinine clearance was identified as the only pre-TIPS factor to be significantly and independently associated with a good clinical response to TIPS for refractory ascites. A good clinical response was observed in 57% of patients with a creatinine clearance >36 ml/min compared to 9% of those with a clearance >36 ml/min (p < 0.01). This cutoff point in creatinine clearance had a sensitivity of 96% and a specificity of 36%: positive predictive and negative predictive values were 57% and 90%, respectively. CONCLUSIONS: TIPS might be useful for the treatment of refractory ascites in cirrhotic patients without severe renal function impairment. However, the TIPS usefulness still has to be demonstrated compared to large volume paracentesis or Leveen shunt. In patients with poor renal function or with liver failure after TIPS, liver transplantation should be considered.


Related Articles

  • PORTOSYSTEMIC SHUNTS: FIVE- AND TEN-YEAR FOLLOW-UPS OF 68 CASES. Wratten, Gary P.; Jahnke, Edward J.; Whelan, Thomas J. // American Journal of Gastroenterology;May1964, Vol. 41 Issue 5, p519 

    Presents information on the long-term follow-up studies on patients undergoing portosystemic shunt procedures for intrahepatic portal obstruction. Description of the long-term effects of portosystemic shunt; Information on the survival and mortality rate of portosystemic shunt; Etiology of the...

  • SEVERE RECURRENT HEPATIC ENCEPHALOPATHY THAT RESPONDED TO ORAL BRANCHED CHAIN AMINO A Cms. Chalasani, N.; Gitlin, Norman // American Journal of Gastroenterology;Jun1996, Vol. 91 Issue 6, p1266 

    Hepatic encephalopathy is a neuropsychiatric syndrome occurring in patients with acute or chronic liver disease. Its pathogenesis remains unclear; however, it appears to be multifactorial. There are several conventional treatments for this condition, such as lactulose, neomycin, and protein...

  • Congenital extrahepatic portosystemic shunts. Murray, Conor P.; Shi-Joon Yoo; Babyn, Paul S.; Yoo, Shi-Joon // Pediatric Radiology;Sep2003, Vol. 33 Issue 9, p614 

    Background: A congenital extrahepatic portosystemic shunt (CEPS) is uncommon. A type 1 CEPS exists where there is absence of intrahepatic portal venous supply and a type 2 CEPS where this supply is preserved. The diagnosis of congenital portosystemic shunt is important because it...


    OBJECTIVE: To determine the precipitating factors and outcome of Hepatic encephalopathy in patients of cirrhosis of liver. STUDY DESIGN: Prospective Descriptive study PLACE AND DURATION: The study was conducted in the department of Medicine Liaquat University of Medical and Health Sciences...

  • Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. Gomez, Eduardo Vilar; Bertot, Luis Calzadilla; Oramas, Bienvenido Gra; Soler, Enrique Arus; Navarro, Raimundo Llanio; Elias, Javier Diaz; JimĂ©nez, Oscar Villa; Vazquez, Maria del Rosario Abreu; Akbar, Sheikh Mohammad Fazle // World Journal of Gastroenterology;6/14/2009, Vol. 15 Issue 22, p2768 

    AIM: To investigate the capability of a biochemical and clinical model, BioCliM, in predicting the survival of cirrhotic patients. METHODS: We prospectively evaluated the survival of 172 cirrhotic patients. The model was constructed using clinical (ascites, encephalopathy and variceal bleeding)...

  • LARGE VOLUME PARACENTESIS -- ALL AT ONCE? Richards, Bob; McCallum, Richard; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Aug1990, Vol. 85 Issue 8, p1039 

    Thirty-eight cirrhotic patients with tense ascites were treated with total paracentesis plus intravenous albumin (6-8 g/L ascites removed). No change from baseline values were noted in liver function tests, renal function tests, plasma volume, plasma renin activity, plasma aldosterone activity,...

  • Prognostic Indicators of Survival in Patients with Cirrhosis and Esophageal Varices, without Previous Bleeding. Merkel, Carlo; Bolognesi, Massimo; Angeli, Paolo; Noventa, Franco; Caregaro, Lorenza; Sacerdoti, David; Gatta, Angelo // American Journal of Gastroenterology;Jul1989, Vol. 84 Issue 7, p717 

    Sixty-one patients with cirrhosis with varices without previous bleeding were admitted to our Department over a period of 2 yr. Fifty had alcoholic cirrhosis. Child-Turcotte- Pugh class was A in 11 patients, B in 30, and C in 20. Varices were F1 in 18, and F2-F3 in 43. During follow-up of up to...

  • Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. Narahara, Yoshiyuki; Kanazawa, Hidenori; Fukuda, Takeshi; Matsushita, Yoko; Harimoto, Hirotomo; Kidokoro, Hideko; Katakura, Tamaki; Atsukawa, Masanori; Taki, Yasuhiko; Kimura, Yuu; Nakatsuka, Katsuhisa; Sakamoto, Choitsu // Journal of Gastroenterology;Jan2011, Vol. 46 Issue 1, p78 

    Background: Transjugular intrahepatic portosystemic shunt (TIPS) has recently been reported to be effective in the treatment of cirrhotic patients with refractory ascites. However, the clinical utility of TIPS in the subset of refractory ascitic patients with good hepatic and renal function is...

  • Vascular Plug-Assisted Retrograde Transvenous Obliteration of Portosystemic Shunts for Refractory Hepatic Encephalopathy: A Case Report. Park, Jonathan K.; Sung-Ki Cho; Stephen Kee; Lee, Edward W. // Case Reports in Radiology;2014, p1 

    While balloon-assisted retrograde transvenous obliteration (BRTO) has been used for two decades in Asia for the management of gastric variceal bleeding, it is still an emerging therapy elsewhere. Given the shunt closure brought about by the procedure, BRTO has also been used for the management...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics